On the public citation graph

Lansoprazole is an antituberculous prodrug targeting cytochrome bc1

https://doi.org/10.1038/ncomms8659
0 signed · 211 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cmdc.201200428openalex-snapshot
Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against Tuberculosis
inferredcites →https://doi.org/10.1002/emmm.201201689openalex-snapshot
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
inferredcites →https://doi.org/10.1002/emmm.201201772openalex-snapshot
Tuberculosis drug discovery in the post‐post‐genomic era
inferredcites →https://doi.org/10.1002/emmm.201303575openalex-snapshot
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
inferredcites →https://doi.org/10.1016/j.chom.2014.09.008openalex-snapshot
Anticytolytic Screen Identifies Inhibitors of Mycobacterial Virulence Protein Secretion
inferredcites →https://doi.org/10.1016/s0022-3565(25)12938-8openalex-snapshot
Identification of the human P450 enzymes involved in lansoprazole metabolism.
inferredcites →https://doi.org/10.1021/cb300151mopenalex-snapshot
Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
inferredcites →https://doi.org/10.1038/ncomms1060openalex-snapshot
A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
inferredcites →https://doi.org/10.1038/ncomms5029openalex-snapshot
Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action
inferredcites →https://doi.org/10.1038/nm.3262openalex-snapshot
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
inferredcites →https://doi.org/10.1038/nrd2468openalex-snapshot
Prodrugs: design and clinical applications
inferredcites →https://doi.org/10.1038/nrd3975openalex-snapshot
Platforms for antibiotic discovery
inferredcites →https://doi.org/10.1038/nrd4001openalex-snapshot
Advances in the development of new tuberculosis drugs and treatment regimens
inferredcites →https://doi.org/10.1038/nrmicro1955openalex-snapshot
Revisiting the host as a growth medium
inferredcites →https://doi.org/10.1073/pnas.1118370109openalex-snapshot
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds
inferredcites →https://doi.org/10.1074/jbc.m708608200openalex-snapshot
Inhibitor-complexed Structures of the Cytochrome bc1 from the Photosynthetic Bacterium Rhodobacter sphaeroides
inferredcites →https://doi.org/10.1093/ajhp/56.suppl_4.s11openalex-snapshot
Safety profile of the proton-pump inhibitors
inferredcites →https://doi.org/10.1128/aac.01125-12openalex-snapshot
Streptomycin-Starved Mycobacterium tuberculosis 18b, a Drug Discovery Tool for Latent Tuberculosis
inferredcites →https://doi.org/10.1128/aac.01423-09openalex-snapshot
Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis
inferredcites →https://doi.org/10.1128/aac.01476-12openalex-snapshot
In Vitro Combination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1128/aac.03486-14openalex-snapshot
Respiratory Flexibility in Response to Inhibition of Cytochrome c Oxidase in Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1248/cpb.38.2853openalex-snapshot
Synthesis of 2-(((4-fluoroalkoxy-2-pyridyl)methyl)sulfinyl)-1H-benzimidazoles as antiulcer agents.
inferredcites →https://doi.org/10.1371/journal.pone.0052951openalex-snapshot
Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
inferredcites →https://doi.org/10.1592/phco.23.13.74s.31929openalex-snapshot
Pharmacologic Properties of Proton Pump Inhibitors

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4765237openalex-extracted
New Synergistic Benzoquinone Scaffolds as Inhibitors of Mycobacterial Cytochrome Bc1 Complex to Treat Multi-Drug Resistant Tuberculosis
inferred← citeshttps://doi.org/10.1002/adma.202406143openalex-snapshot
NIR‐II AIE Luminogen‐Based Erythrocyte‐Like Nanoparticles with Granuloma‐Targeting and Self‐Oxygenation Characteristics for Combined Phototherapy of Tuberculosis
inferred← citeshttps://doi.org/10.1002/advs.202308312openalex-snapshot
Structural Relationships to Efficacy for Prazole‐Derived Antivirals
inferred← citeshttps://doi.org/10.1002/ange.202414325openalex-snapshot
Innovative Wirkstoffe aus der antibakteriellen Forschung im Kampf gegen mikrobielle Resistenzen
inferred← citeshttps://doi.org/10.1002/anie.202414325openalex-snapshot
Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research
inferred← citeshttps://doi.org/10.1002/ardp.201800248openalex-snapshot
Interconnection of sulfides and sulfoxides in medicinal chemistry
inferred← citeshttps://doi.org/10.1002/ardp.202000419openalex-snapshot
3‐Aryl‐substituted imidazo[1,2‐a]pyridines as antituberculosis agents
inferred← citeshttps://doi.org/10.1002/bkcs.10765openalex-snapshot
Putative 3D Structure of QcrB from Mycobacterium tuberculosis Cytochrome bc1 Complex, a Novel Drug‐Target for New Series of Antituberculosis Agent Q203
inferred← citeshttps://doi.org/10.1002/bmc.4035openalex-snapshot
Lansoprazole‐sulfide, pharmacokinetics of this promising anti‐tuberculous agent
inferred← citeshttps://doi.org/10.1002/chem.201901640openalex-snapshot
Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation towards Mycobacterium Tuberculosis and Plasmodium Falciparum
inferred← citeshttps://doi.org/10.1002/cmdc.201800720openalex-snapshot
Synthesis of Long‐Chain β‐Lactones and Their Antibacterial Activities against Pathogenic Mycobacteria
inferred← citeshttps://doi.org/10.1002/cmdc.201800755openalex-snapshot
Unpacking the Pathogen Box—An Open Source Tool for Fighting Neglected Tropical Disease
inferred← citeshttps://doi.org/10.1002/cmdc.202100004openalex-snapshot
Benzimidazoles in Drug Discovery: A Patent Review
inferred← citeshttps://doi.org/10.1002/cmdc.202200631openalex-snapshot
A Reinvestigation of the Role of the Sorbic Acid Tail on the Antibacterial and Anti‐Tuberculosis Properties of Moiramide B
inferred← citeshttps://doi.org/10.1002/med.21779openalex-snapshot
QcrB in Mycobacterium tuberculosis: The new drug target of antitubercular agents
inferred← citeshttps://doi.org/10.1002/med.22100openalex-snapshot
The Emerging Landscape of Tubercular Targets: A Medicinal Chemistry Approach
inferred← citeshttps://doi.org/10.1002/path.5407openalex-snapshot
Effects of host‐directed therapies on the pathology of tuberculosis
inferred← citeshttps://doi.org/10.1002/slct.73573openalex-snapshot
Rational Design, Synthesis, Biological Evaluation, and Molecular Modeling of Novel Thiazole‐Acetamide Derivatives as Antitubercular Agents
inferred← citeshttps://doi.org/10.1007/978-3-031-15955-8_45openalex-snapshot
Multiomics Integration of Tuberculosis Pathogenesis
inferred← citeshttps://doi.org/10.1007/s00232-017-9997-3openalex-snapshot
Mycobacterial Membrane Proteins QcrB and AtpE: Roles in Energetics, Antibiotic Targets, and Associated Mechanisms of Resistance
inferred← citeshttps://doi.org/10.1007/s00253-020-10606-yopenalex-snapshot
Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus
inferred← citeshttps://doi.org/10.1007/s00436-025-08526-9openalex-snapshot
The therapeutic effects of vonoprazan against giardiasis in rats: parasitological, pathological, and immunological aspects
inferred← citeshttps://doi.org/10.1007/s00894-021-04993-wopenalex-snapshot
Ursolic acid as a potential inhibitor of Mycobacterium tuberculosis cytochrome bc1 oxidase—a molecular modelling perspective
inferred← citeshttps://doi.org/10.1007/s10695-026-01692-2openalex-snapshot
A lansoprazole-like structure derived from Streptomyces metabolites: evaluation of its protective effects on hepatorenal function, antioxidant activity, and immune parameters in African catfish challenged with Staphylococcus aureus
inferred← citeshttps://doi.org/10.1007/s11030-021-10335-yopenalex-snapshot
Targeting the cytochrome bc1 complex for drug development in M. tuberculosis: review
inferred← citeshttps://doi.org/10.1007/s11030-026-11534-1openalex-snapshot
Integrated computational and experimental approaches for drug repurposing targeting key Mycobacterium tuberculosis proteins
inferred← citeshttps://doi.org/10.1007/s11686-025-01187-9openalex-snapshot
Comparing the Interactions of Trichomonas vaginalis/gallinae Legumain-Like Cysteine Protease 1 (LEGU-1) and Human Legumain (LGMN) Protein Sequences with Proton Pump Inhibitor Drugs (Lansoprazole, Omeprazole, and Esomeprazole) by Bioinformatics Analyses
inferred← citeshttps://doi.org/10.1007/s12272-015-0645-0openalex-snapshot
Next-generation antimicrobials: from chemical biology to first-in-class drugs
inferred← citeshttps://doi.org/10.1007/s42452-019-0715-xopenalex-snapshot
Bio-nanobactericides: an emanating class of nanoparticles towards combating multi-drug resistant pathogens
inferred← citeshttps://doi.org/10.1016/b978-0-323-85873-1.00006-xopenalex-snapshot
Combination drug delivery approaches for tuberculosis
inferred← citeshttps://doi.org/10.1016/b978-0-443-27735-1.00008-3openalex-snapshot
Revolutionizing TB therapy: Emerging opportunities and unresolved challenges
inferred← citeshttps://doi.org/10.1016/b978-0-443-36518-8.00021-7openalex-snapshot
Innovative platforms for drug discovery against mycobacteria: The success and challenges
inferred← citeshttps://doi.org/10.1016/bs.armc.2019.05.001openalex-snapshot
Inhibitors of enzymes in the electron transport chain of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.apsb.2025.01.023openalex-snapshot
Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizon
inferred← citeshttps://doi.org/10.1016/j.bioorg.2018.08.025openalex-snapshot
Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis
inferred← citeshttps://doi.org/10.1016/j.bioorg.2023.106659openalex-snapshot
Synthesis and antitubercular activity of novel 4-arylalkyl substituted thio-, oxy- and sulfoxy-quinoline analogues targeting the cytochrome bc1 complex
inferred← citeshttps://doi.org/10.1016/j.bioorg.2024.108093openalex-snapshot
Recent advancements in the quest of benzazoles as anti-Mycobacterium tuberculosis agents
inferred← citeshttps://doi.org/10.1016/j.bmcl.2017.08.057openalex-snapshot
Ester-prodrugs of ethambutol control its antibacterial activity and provide rapid screening for mycobacterial hydrolase activity
inferred← citeshttps://doi.org/10.1016/j.bmcl.2022.128692openalex-snapshot
Design, synthesis and antibacterial activity against pathogenic mycobacteria of conjugated hydroxamic acids, hydrazides and O-alkyl/O-acyl protected hydroxamic derivatives
inferred← citeshttps://doi.org/10.1016/j.carbpol.2023.121198openalex-snapshot
Cyclodextrin-based metal-organic framework materials: Classifications, synthesis strategies and applications in variegated delivery systems
inferred← citeshttps://doi.org/10.1016/j.cclet.2020.04.007openalex-snapshot
New antituberculosis drugs targeting the respiratory chain
inferred← citeshttps://doi.org/10.1016/j.ccr.2021.214121openalex-snapshot
Antimicrobial MOFs
inferred← citeshttps://doi.org/10.1016/j.chembiol.2023.12.007openalex-snapshot
Discovery of dual-active ethionamide boosters inhibiting the Mycobacterium tuberculosis ESX-1 secretion system
inferred← citeshttps://doi.org/10.1016/j.copbio.2017.03.023openalex-snapshot
Novel and revisited approaches in antituberculosis drug discovery
inferred← citeshttps://doi.org/10.1016/j.coph.2018.06.006openalex-snapshot
Therapeutic potential of promiscuous targets in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.09.006openalex-snapshot
New prodrugs against tuberculosis
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.09.010openalex-snapshot
Identification and validation of novel drug targets in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.09.025openalex-snapshot
Learning from the past for TB drug discovery in the future
inferred← citeshttps://doi.org/10.1016/j.drudis.2017.05.005openalex-snapshot
Host-directed therapies offer novel opportunities for the fight against tuberculosis
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.03.020openalex-snapshot
Drug discovery in tuberculosis. New drug targets and antimycobacterial agents
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.06.005openalex-snapshot
1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116479openalex-snapshot
New synergistic benzoquinone scaffolds as inhibitors of mycobacterial cytochrome bc1 complex to treat multi-drug resistant tuberculosis
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116849openalex-snapshot
Replacement of the essential nitro group by electrophilic warheads towards nitro-free antimycobacterial benzothiazinones
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.118010openalex-snapshot
Discovery of novel Cytochrome bd oxidase inhibitors against Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.eurpolymj.2021.110387openalex-snapshot
Sulfur-based oxidation-responsive polymers. Chemistry, (chemically selective) responsiveness and biomedical applications
inferred← citeshttps://doi.org/10.1016/j.foodchem.2025.146964openalex-snapshot
11,12-dihydrolactaroviolin from edible mushroom Lactarius hatsudake Tanaka as a selective inhibitor of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1016/j.gendis.2025.101817openalex-snapshot
Targeting fatty acid synthase to overcome PARP inhibitor resistance and to create an artificial synthetic lethality for triple-negative breast cancer
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2017.08.023openalex-snapshot
Activity of 2-(quinolin-4-yloxy)acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing
inferred← citeshttps://doi.org/10.1016/j.ijantimicag.2017.12.001openalex-snapshot
Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2017.05.056openalex-snapshot
Cyclodextrin-based metal-organic frameworks particles as efficient carriers for lansoprazole: Study of morphology and chemical composition of individual particles
inferred← citeshttps://doi.org/10.1016/j.jbc.2023.105483openalex-snapshot
A simple assay for inhibitors of mycobacterial oxidative phosphorylation
inferred← citeshttps://doi.org/10.1016/j.jff.2019.103539openalex-snapshot
Protective effects of camellia oil (Camellia brevistyla) against indomethacin-induced gastrointestinal mucosal damage in vitro and in vivo
inferred← citeshttps://doi.org/10.1016/j.jmgm.2022.108347openalex-snapshot
Investigation of protein-ligand binding motions through protein conformational morphing and clustering of cytochrome bc1-aa3 super complex
inferred← citeshttps://doi.org/10.1016/j.jpba.2020.113146openalex-snapshot
Qualitative and quantitative determination of anaprazole and its major metabolites in human plasma
inferred← citeshttps://doi.org/10.1016/j.mib.2017.11.017openalex-snapshot
Host–pathogen systems for early drug discovery against tuberculosis
inferred← citeshttps://doi.org/10.1016/j.mib.2018.02.006openalex-snapshot
Priming the tuberculosis drug pipeline: new antimycobacterial targets and agents
inferred← citeshttps://doi.org/10.1016/j.micpath.2025.107515openalex-snapshot
Recent advances in inhibitor development and metabolic targeting in tuberculosis therapy
inferred← citeshttps://doi.org/10.1016/j.pbiomolbio.2019.11.002openalex-snapshot
Cytochrome bd in Mycobacterium tuberculosis: A respiratory chain protein involved in the defense against antibacterials
inferred← citeshttps://doi.org/10.1016/j.pbiomolbio.2020.02.001openalex-snapshot
Targeting the cytochrome oxidases for drug development in mycobacteria
inferred← citeshttps://doi.org/10.1016/j.pharmr.2025.100105openalex-snapshot
Targeting fatty acid synthase for cancer drug discovery: Retrospective analyses and outlook
inferred← citeshttps://doi.org/10.1016/j.rechem.2023.101013openalex-snapshot
A critical review of benzimidazole: Sky-high objectives towards the lead molecule to predict the future in medicinal chemistry
inferred← citeshttps://doi.org/10.1016/j.resinv.2024.11.004openalex-snapshot
Association of acid-suppressive therapy and tuberculosis: A causal or coincidental link to the infection?
inferred← citeshttps://doi.org/10.1016/j.semcancer.2017.01.008openalex-snapshot
Therapeutic implications of tumor interstitial acidification
inferred← citeshttps://doi.org/10.1016/j.trsl.2020.03.007openalex-snapshot
New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
inferred← citeshttps://doi.org/10.1016/j.tube.2017.06.004openalex-snapshot
Enabling faster Go/No-Go decisions through secondary screens in anti-mycobacterial drug discovery
inferred← citeshttps://doi.org/10.1016/j.tube.2018.08.004openalex-snapshot
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase
inferred← citeshttps://doi.org/10.1016/j.xphs.2016.07.004openalex-snapshot
Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c00642openalex-snapshot
Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid Synthase
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5b01542openalex-snapshot
Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00912openalex-snapshot
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β- d -ribofuranose 2′-Oxidase
inferred← citeshttps://doi.org/10.1021/acschemneuro.1c00185openalex-snapshot
Proton Pump Inhibitor “Lansoprazole” Inhibits Locus Coeruleus’s Neuronal Activity and Increases Rapid Eye Movement Sleep
inferred← citeshttps://doi.org/10.1021/acsinfecdis.0c00622openalex-snapshot
Design and Synthesis of Pyrano[3,2- b ]indolones Showing Antimycobacterial Activity
inferred← citeshttps://doi.org/10.1021/acsinfecdis.2c00283openalex-snapshot
Identification of 2-Aryl-Quinolone Inhibitors of Cytochrome bd and Chemical Validation of Combination Strategies for Respiratory Inhibitors against Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1021/acsinfecdis.2c00448openalex-snapshot
Synthesis and Biological Characterization of Fluorescent Cyclipostins and Cyclophostin Analogues: New Insights for the Diagnosis of Mycobacterial-Related Diseases
inferred← citeshttps://doi.org/10.1021/acsinfecdis.5b00154openalex-snapshot
Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB
inferred← citeshttps://doi.org/10.1021/acsinfecdis.7b00255openalex-snapshot
The Expanding Diversity of Mycobacterium tuberculosis Drug Targets
inferred← citeshttps://doi.org/10.1021/acsinfecdis.8b00225openalex-snapshot
Pyrazolo[1,5-a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis
inferred← citeshttps://doi.org/10.1021/acsinfecdis.9b00449openalex-snapshot
Features and Functional Importance of Key Residues of the Mycobacterium tuberculosis Cytochrome bd Oxidase
inferred← citeshttps://doi.org/10.1021/acsomega.2c01613openalex-snapshot
Prediction of QcrB Inhibition as a Measure of Antitubercular Activity with Machine Learning Protocols
inferred← citeshttps://doi.org/10.1021/jacs.3c09587openalex-snapshot
Chemical Biology Approach to Reveal the Importance of Precise Subcellular Targeting for Intracellular Staphylococcus aureus Eradication
inferred← citeshttps://doi.org/10.1038/s41467-019-08405-9openalex-snapshot
Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition
inferred← citeshttps://doi.org/10.1038/s41467-025-64662-xopenalex-snapshot
Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1038/s41598-018-20989-8openalex-snapshot
The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd
inferred← citeshttps://doi.org/10.1038/s41598-019-45164-5openalex-snapshot
Nitrogen deprivation induces triacylglycerol accumulation, drug tolerance and hypervirulence in mycobacteria
inferred← citeshttps://doi.org/10.1038/s41598-024-75818-yopenalex-snapshot
An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates
inferred← citeshttps://doi.org/10.1038/s41598-025-10668-wopenalex-snapshot
In vitro susceptibility testing of Trichomonas gallinae strains to proton pump inhibitors and nitroimidazoles
inferred← citeshttps://doi.org/10.1038/s42003-025-09309-9openalex-snapshot
Mycobacterial respiratory chain enzymes and growth are inhibited by decylubiquinone
inferred← citeshttps://doi.org/10.1038/s44386-025-00008-3openalex-snapshot
Structural and mechanistic study of a novel inhibitor analogue of M. tuberculosis cytochrome bc1:aa3
inferred← citeshttps://doi.org/10.1038/srep46595openalex-snapshot
Data Intensive Genome Level Analysis for Identifying Novel, Non-Toxic Drug Targets for Multi Drug Resistant Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1039/c6md00236fopenalex-snapshot
SAR and identification of 2-(quinolin-4-yloxy)acetamides as Mycobacterium tuberculosis cytochrome bc 1 inhibitors
inferred← citeshttps://doi.org/10.1039/c8ob02777copenalex-snapshot
Synthesis of modified β-methoxyphenylalanines via diazonium chemistry and their incorporation in desoxycyclomarin analogues
inferred← citeshttps://doi.org/10.1039/d2ra02163copenalex-snapshot
Pyridine appended 2-hydrazinylthiazole derivatives: design, synthesis, in vitro and in silico antimycobacterial studies
inferred← citeshttps://doi.org/10.1039/d4nj04870aopenalex-snapshot
Metal-coordination-driven self-assembly of DNA nanohybrids for robust intracellular anti-tuberculosis therapy
inferred← citeshttps://doi.org/10.1073/pnas.1521988112openalex-snapshot
Antiinfectives targeting enzymes and the proton motive force
inferred← citeshttps://doi.org/10.1073/pnas.1706139114openalex-snapshot
Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection
inferred← citeshttps://doi.org/10.1073/pnas.2215512120openalex-snapshot
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
inferred← citeshttps://doi.org/10.1073/pnas.2412780121openalex-snapshot
Inhibition mechanism of potential antituberculosis compound lansoprazole sulfide
inferred← citeshttps://doi.org/10.1074/jbc.ra118.005732openalex-snapshot
Inhibitors of energy metabolism interfere with antibiotic-induced death in mycobacteria
inferred← citeshttps://doi.org/10.1080/07391102.2019.1688196openalex-snapshot
Refined homology model of cytochrome bcc complex B subunit for virtual screening of potential anti-tuberculosis agents
inferred← citeshttps://doi.org/10.1080/10409238.2025.2545785openalex-snapshot
Breakthroughs in the development of antibiotics, antifungals and antiparasitics targeting the pathogens’ respiratory chain
inferred← citeshttps://doi.org/10.1080/13543776.2022.2012151openalex-snapshot
An updated patent review on drugs for the treatment of tuberculosis (2018-present)
inferred← citeshttps://doi.org/10.1080/14787210.2020.1760845openalex-snapshot
Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs
inferred← citeshttps://doi.org/10.1080/17460441.2020.1696771openalex-snapshot
Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discovery
inferred← citeshttps://doi.org/10.1080/22221751.2024.2322649openalex-snapshot
Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris
inferred← citeshttps://doi.org/10.1080/22221751.2024.2396869openalex-snapshot
Response to the letter to the editor: Lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris *
inferred← citeshttps://doi.org/10.1089/ars.2020.8039openalex-snapshot
Bacterial Oxidases of the Cytochrome bd Family: Redox Enzymes of Unique Structure, Function, and Utility As Drug Targets
inferred← citeshttps://doi.org/10.1089/mdr.2021.0424openalex-snapshot
Molecular Mechanisms of MmpL3 Function and Inhibition
inferred← citeshttps://doi.org/10.1098/rstb.2015.0506openalex-snapshot
Inhibiting Mycobacterium tuberculosis within and without
inferred← citeshttps://doi.org/10.1101/2025.02.15.638392openalex-snapshot
Reference-based chemical-genetic interaction profiling to elucidate small molecule mechanism of action in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1101/2025.08.27.672670openalex-snapshot
Identification and characterization of host-directed therapeutics for tuberculosis using a versatile human 3D tuberculoma bioplatform
inferred← citeshttps://doi.org/10.1111/febs.16645openalex-snapshot
Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis
inferred← citeshttps://doi.org/10.1111/mmi.13535openalex-snapshot
Identification of aminopyrimidine‐sulfonamides as potent modulators of Wag31‐mediated cell elongation in mycobacteria
inferred← citeshttps://doi.org/10.1128/9781555819569.ch14openalex-snapshot
Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions
inferred← citeshttps://doi.org/10.1128/aac.00251-23openalex-snapshot
Characterization of Two Novel Inhibitors of the Mycobacterium tuberculosis Cytochrome bc 1 Complex
inferred← citeshttps://doi.org/10.1128/aac.00326-16openalex-snapshot
New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria
inferred← citeshttps://doi.org/10.1128/aac.00478-25openalex-snapshot
Vacuolar-ATPase inhibitors are antimicrobial agents active against intracellular mycobacteria
inferred← citeshttps://doi.org/10.1128/aac.00762-22openalex-snapshot
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection
inferred← citeshttps://doi.org/10.1128/aac.00956-21openalex-snapshot
Nitric Oxide-Dependent Electron Transport Chain Inhibition by the Cytochrome bc 1 Inhibitor and Pretomanid Combination Kills Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1128/aac.01008-19openalex-snapshot
Extremely Low Hit Rate in a Diverse Chemical Drug Screen Targeting Mycobacterium abscessus
inferred← citeshttps://doi.org/10.1128/aac.01317-18openalex-snapshot
No Evidence for Acquired Mutations Associated with Cytochrome bc 1 Inhibitor Resistance in 13,559 Clinical Mycobacterium tuberculosis Complex Isolates
inferred← citeshttps://doi.org/10.1128/aac.01523-16openalex-snapshot
Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1128/aac.01677-17openalex-snapshot
Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1128/aac.02041-21openalex-snapshot
Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1128/aac.02661-18openalex-snapshot
Novel MenA Inhibitors Are Bactericidal against Mycobacterium tuberculosis and Synergize with Electron Transport Chain Inhibitors
inferred← citeshttps://doi.org/10.1128/jb.00152-18openalex-snapshot
Roles of Alanine Dehydrogenase and Induction of Its Gene in Mycobacterium smegmatis under Respiration-Inhibitory Conditions
inferred← citeshttps://doi.org/10.1128/mbio.00272-17openalex-snapshot
Targeting Energy Metabolism in Mycobacterium tuberculosis , a New Paradigm in Antimycobacterial Drug Discovery
inferred← citeshttps://doi.org/10.1128/mbio.01276-18openalex-snapshot
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1128/microbiolspec.tbtb2-0014-2016openalex-snapshot
Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions
inferred← citeshttps://doi.org/10.1128/msphere.00606-19openalex-snapshot
Identification of 4-Amino-Thieno[2,3- d ]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.1128/spectrum.00484-26openalex-snapshot
High-throughput screening system for antimycobacterial compounds using in vitro infected cells: construction and application to compounds in the Ōmura Natural Compound Library
inferred← citeshttps://doi.org/10.1128/spectrum.03968-25openalex-snapshot
Activity of MMV Pandemic Response Box compounds against Mycobacterium ulcerans viability and mycolactone production
inferred← citeshttps://doi.org/10.1155/2020/3767915openalex-snapshot
Ion Transport Modulators as Antimycobacterial Agents
inferred← citeshttps://doi.org/10.1172/jci.insight.145704openalex-snapshot
Identification of a series of hair-cell MET channel blockers that protect against aminoglycoside-induced ototoxicity
inferred← citeshttps://doi.org/10.1186/s43094-021-00196-5openalex-snapshot
Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance
inferred← citeshttps://doi.org/10.12692/ijb/15.2.281-296openalex-snapshot
Urgency of novel anti-tuberculosis strategies: a prospective challenge
inferred← citeshttps://doi.org/10.1371/journal.pmed.1002457openalex-snapshot
Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort
inferred← citeshttps://doi.org/10.1371/journal.pone.0218449openalex-snapshot
Cordycepin kills Mycobacterium tuberculosis through hijacking the bacterial adenosine kinase
inferred← citeshttps://doi.org/10.1371/journal.pone.0227224openalex-snapshot
Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds
inferred← citeshttps://doi.org/10.1371/journal.pone.0238178openalex-snapshot
Dissecting the antibacterial activity of oxadiazolone-core derivatives against Mycobacterium abscessus
inferred← citeshttps://doi.org/10.1371/journal.ppat.1008270openalex-snapshot
New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.15252/emmm.202013207openalex-snapshot
Dual inhibition of the terminal oxidases eradicates antibiotic‐tolerant Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2903522/v1openalex-snapshot
Pharmacophore, atom-based 3D-QSAR modeling and binding mode analysis of QcrB inhibitors as potential tuberculosis agents
inferred← citeshttps://doi.org/10.2174/0113892010307169240619061808openalex-snapshot
Nanosponges-road Less Explored Changing Drug Delivery Approach: An Explicative Review
inferred← citeshttps://doi.org/10.2174/1385272824666191213123930openalex-snapshot
An Overview of Recent Advances in Biological and Pharmaceutical Developments of Fluoro-containing Drugs
inferred← citeshttps://doi.org/10.2174/1389450124666230505145335openalex-snapshot
Multitargeting: An Alternative Approach to Tackle Multidrug Resistance in Tuberculosis
inferred← citeshttps://doi.org/10.2174/1874467214666210928152512openalex-snapshot
Cytochrome bc1-aa3 Oxidase Supercomplex As Emerging and Potential Drug Target Against Tuberculosis
inferred← citeshttps://doi.org/10.22159/ajpcr.2023.v16i5.46809openalex-snapshot
ASSESSMENT AND OUTCOME ON PREPARATIONS, CHARACTERIZATION OF TOPICAL TARGETED NANOSPONGE BASED DRUG DELIVERY: CRITICAL REVIEW
inferred← citeshttps://doi.org/10.22270/ujpr.v4i1.239openalex-snapshot
DEVELOPMENT AND EVALUATION OF NANOSPONGES LOADED EXTENDED RELEASE TABLETS OF LANSOPRAZOLE
inferred← citeshttps://doi.org/10.3238/persinfek.2016.05.27.02openalex-snapshot
Tuberkulose: Neue Therapieformen
inferred← citeshttps://doi.org/10.32657/10356/152336openalex-snapshot
Exploiting reductive evolution in Mycobacterium ulcerans to develop a single-dose cure for Buruli ulcer
inferred← citeshttps://doi.org/10.32657/10356/155550openalex-snapshot
Suffocating tuberculosis : oxidative phosphorylation as a target space for the development of next generation anti-tuberculosis drugs
inferred← citeshttps://doi.org/10.32657/10356/155733openalex-snapshot
Evaluating the attractiveness of the terminal oxidases as drug targets in mycobacterium abscessus
inferred← citeshttps://doi.org/10.32657/10356/163190openalex-snapshot
Structure and regulation of the mycobacterial F1-ATPase
inferred← citeshttps://doi.org/10.33612/diss.1069244528openalex-snapshot
Bacterial membranes in life and death
inferred← citeshttps://doi.org/10.33612/diss.130530955openalex-snapshot
Mining and characterization of antimicrobials from plant growth-promoting rhizobacteria isolated from perennial ryegrass
inferred← citeshttps://doi.org/10.3389/fcimb.2020.589318openalex-snapshot
Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?
inferred← citeshttps://doi.org/10.3389/fcimb.2020.611683openalex-snapshot
Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.3389/fmicb.2018.02895openalex-snapshot
Transcriptional Approach for Decoding the Mechanism of rpoC Compensatory Mutations for the Fitness Cost in Rifampicin-Resistant Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.3389/fmicb.2024.1439814openalex-snapshot
Discovery of anti-infective compounds against Mycobacterium marinum after biotransformation of simple natural stilbenes by a fungal secretome
inferred← citeshttps://doi.org/10.3389/fonc.2019.00075openalex-snapshot
The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management
inferred← citeshttps://doi.org/10.3389/fphar.2017.00689openalex-snapshot
Addressing the Challenges of Tuberculosis: A Brief Historical Account
inferred← citeshttps://doi.org/10.3390/app10072339openalex-snapshot
Oxidative Phosphorylation—an Update on a New, Essential Target Space for Drug Discovery in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.3390/app10134629openalex-snapshot
Multi-Omics Technologies Applied to Tuberculosis Drug Discovery
inferred← citeshttps://doi.org/10.3390/microorganisms8081096openalex-snapshot
Comprehensive Host Cell-Based Screening Assays for Identification of Anti-Virulence Drugs Targeting Pseudomonas aeruginosa and Salmonella Typhimurium
inferred← citeshttps://doi.org/10.3390/molecules27217252openalex-snapshot
Comparison of the Hydride-Donating Ability and Activity of Five- and Six-Membered Benzoheterocyclic Compounds in Acetonitrile
inferred← citeshttps://doi.org/10.3390/pathogens7010024openalex-snapshot
Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery
inferred← citeshttps://doi.org/10.3390/ph13090227openalex-snapshot
SAR Analysis of Small Molecules Interfering with Energy-Metabolism in Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.36468/pharmaceutical-sciences.1290openalex-snapshot
Nanosponge-An Emerging Nanomaterial in Recent Advancement of Novel Drug Delivery: An Overview and Future Perspectives
inferred← citeshttps://doi.org/10.37489/0235-2990-2022-67-3-4-4-15openalex-snapshot
Assessment of Antimycobacterial Activity of Newly Synthesized Pyrimidine Derivatives Against Mycobacterium tuberculosis
inferred← citeshttps://doi.org/10.38212/2224-6614.3394openalex-snapshot
Repurposing Lansoprazole and Posaconazole to treat Leishmaniasis: Integration of in vitro testing, pharmacological corroboration, and mechanisms of action
inferred← citeshttps://doi.org/10.52692/1857-0011.2021.3-71.30openalex-snapshot
Energy metabolism inhibitors - a new group of antituberculous drugs
inferred← citeshttps://doi.org/10.5937/sanamed0-51644openalex-snapshot
Multiomics integration in anti-tuberculosis drug discovery
inferred← citeshttps://doi.org/10.70675/17454efaz4e04z4db1za1f0z399386aabcd7openalex-snapshot
La spectroscopie de résonance magnétique nucléaire à l'état solide : un outil pour la caractérisation des systèmes poreux de délivrance de médicaments
inferred← citeshttps://doi.org/10.70675/63928fb8za636z4a6fzaae4zbb2fb819dd68openalex-snapshot
Etude du potentiel thérapeutique d'analogues de cyclipostins & cyclophostines et de dérivés d'oxadiazolones sur Mycobacterium abscessus
inferred← citeshttps://doi.org/10.70675/b1318398z3b3ez47caza99cz49045a043924openalex-snapshot
Implication des enzymes lipolytiques dans la virulence et la survie mycobactérienne
inferred← citeshttps://doi.org/10.70675/db80d0f9z6842z4676z84d0ze2c15620b6fbopenalex-snapshot
Deciphering antimycobacterial activity of cyclophostin/cyclipostins analogs and oxadiazolones derivatives, two new promising family compounds in the treatment of tuberculosis and mycobacterial-related diseases
inferred← citeshttps://doi.org/10.7554/elife.71959openalex-snapshot
Structure of mycobacterial CIII2CIV2 respiratory supercomplex bound to the tuberculosis drug candidate telacebec (Q203)
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.